Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin
暂无分享,去创建一个
D. Reinhardt | H. Jürgens | A. Biondi | G. Kaspers | K. Hählen | E. V. Wering | O. Smith | D. Huismans | E. Wering | C. Zwaan | J. Feingold | G. Kaspers | D R Huismans | E R van Wering